From my basic research, Cognigram has been available in Canada since 2013, but I can't find much information from company reports regarding the level of market penetration or revenue that it has garnered... Do you believe that Cognigram will be a bigger commercial success in the United States? Don't get me wrong, I work in the cognitive sciences area, and can totally understand that Cognigram would be a fantastic product that provides a much-needed update to traditional pen/paper practises of screening for dementia/cognitive impairment. It would be great to hear how the company has learned from Canada in terms of whether they will tweak pricing/marketing tactics for the U.S. rollout. I guess more information in this regard will be provided across FY18.
Hoping to take up a (relatively) small-moderate position in CGS as more Cognigram info is provided.
Cheers
From my basic research, Cognigram has been available in Canada...
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.000(0.00%) |
Mkt cap ! $239.9M | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.43 | $1.40 | $95.75K | 67.72K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7889 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.44 | 4971 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.41 |
Change
0.000 ( 1.08 %) |
||||
| Open | High | Low | Volume | ||
| $1.42 | $1.43 | $1.40 | 11600 | ||
| Last updated 15.58pm 06/05/2024 ? | |||||
| CGS (ASX) Chart |